- Q1 2024 Merck KGaA Earnings Call TranscriptMay 15, 2024€165.78 (+4.47%)Earnings
- Q4 2023 Merck KGaA Earnings Press Conference TranscriptMar 07, 2024
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Merck KGaA Earnings Call TranscriptNov 09, 2023€153.83 (+3.52%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 19, 2023
- Q2 2023 Merck KGaA Earnings Call TranscriptAug 03, 2023€163.78 (+3.26%)Earnings
- Q2 2023 Merck KGaA Earnings Press Conference TranscriptAug 03, 2023
- Q1 2023 Merck KGaA Earnings Call TranscriptMay 11, 2023€165.65 (+2.79%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 28, 2023
- Q4 2022 Merck KGaA Earnings Call TranscriptMar 02, 2023€179.83 (+1.64%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Merck KGaA R&D Update Call TranscriptNov 21, 2022
- Q3 2022 Merck KGaA Earnings Call TranscriptNov 10, 2022€177.43 (+3.83%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 06, 2022
- Q2 2022 Merck KGaA Earnings Call TranscriptAug 04, 2022€184.88 (+0.56%)Earnings
- Q1 2022 Merck KGaA Earnings Call TranscriptMay 12, 2022€160.73 (-5.15%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 22, 2022
- Full Year 2021 Merck KGaA Earnings Call TranscriptMar 03, 2022€176.35 (+0.99%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Merck KGaA R&D Update Call TranscriptNov 22, 2021
- Q3 2021 Merck KGaA Earnings Call TranscriptNov 11, 2021€205.5 (-0.36%)Earnings
- Merck KGaA Capital Markets Day (Virtual) TranscriptSep 09, 2021
- Half Year 2021 Merck KGaA Earnings Call TranscriptAug 05, 2021€188.03 (+6.56%)Earnings
- Q1 2021 Merck KGaA Earnings Call TranscriptMay 12, 2021€135.53 (-1.81%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 23, 2021
- Full Year 2020 Merck KGaA Earnings Call TranscriptMar 04, 2021€133.2 (+0.68%)Earnings
- Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call TranscriptJan 20, 2021
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 19, 2020
- Q3 2020 Merck KGaA Earnings Call TranscriptNov 12, 2020€130.7 (-0.63%)Earnings
- Merck KGaA CMD - Healthcare:R&D Update Call TranscriptSep 25, 2020
- Merck KGaA Capital Markets Day (virtual) - Performance Materials: Semiconductor Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - Life Science: Process Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - CEO/CFO Session and Board Q&A TranscriptSep 16, 2020
- Half Year 2020 Merck KGaA Earnings Call TranscriptAug 06, 2020€113.08 (+1.44%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Merck KGaA Earnings Call TranscriptMay 14, 2020€103.25 (-3.14%)Earnings
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptMar 18, 2020
- Full Year 2019 Merck KGaA Earnings Call TranscriptMar 05, 2020€115.35 (+1.27%)Earnings
- Merck KGaA Evobrutinib (RMS) Update Call TranscriptFeb 20, 2020
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Merck KGaA Earnings Call TranscriptNov 14, 2019€106.03 (-3.39%)Earnings
- Merck KGaA Capital Market Day TranscriptSep 11, 2019
- Half Year 2019 Merck KGaA Earnings Call TranscriptAug 08, 2019€94.38 (+1.66%)Earnings
- Merck KGaA R&D Update Call TranscriptJun 14, 2019
- Oncolytics Biotech Inc. - Shareholder/Analyst Call TranscriptJun 05, 2019
- Q1 2019 Merck KGaA Earnings Call TranscriptMay 14, 2019€92.09 (-3.55%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 26, 2019
- Merck KGaA Signs Definitive Agreement to Acquire Versum Materials Call TranscriptApr 12, 2019
- Merck KGaA FDA Approval of MAVENCLAD Conference Call TranscriptApr 01, 2019
- Full Year 2018 Merck KGaA Earnings Call TranscriptMar 07, 2019€93.23 (-0.03%)Earnings
Full Year 2020 Merck KGaA Earnings Call Transcript
Dear ladies and gentlemen, welcome to the Merck Investor and Analyst conference call on Fourth Quarter 2020. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Thank you very much, Diana, and a very warm welcome to this Q4 and Full Year 2020 Earnings Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. Please note that presenting today are Stefan Oschmann, our group CEO; and Marcus Kuhnert, our Group CFO; as well as Kai Beckmann, CEO of our Electronics Business Sector previously PM. For a short introduction to the capital markets, Peter Guenter, our new CEO of our Healthcare business sector, is also joining this call and will be available for the Q&A. Please note that Danny Bar-Zohar, our Healthcare Global Head of Development is also available for questions. Lastly, I'm delighted to let you know that Belen Garijo, Vice Chair of the Executive Board and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)